In humans, elevated hepcidin was observed in a variety of inflammatory disorders including rheumatologic diseases, inflammatory bowel disease, infections, multiple myeloma, and critical illness [13, 35–37, 54, 55]. This evidence concerns the gene HAMP and plasma cell myeloma.